These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6130330)

  • 1. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ; McKay A; McArdle B; Leiberman P; Pollock JG; Lowe GD; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):315-7. PubMed ID: 6130330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
    Hossman V; Heinen A; Auel H; FitzGerald GA
    Thromb Res; 1981 May; 22(4):481-90. PubMed ID: 7027528
    [No Abstract]   [Full Text] [Related]  

  • 3. Intra-arterial prostacyclin compared to Praxilene in the management of severe lower limb ischaemia: a double blind trial.
    Negus D; Irving JD; Friedgood A
    J Cardiovasc Surg (Torino); 1987; 28(2):196-9. PubMed ID: 2435738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
    Belch JJ; Newman P; Drury JK; McKenzie F; Capell H; Leiberman P; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):313-5. PubMed ID: 6130329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease.
    Cronenwett JL; Zelenock GB; Whitehouse WM; Lindenauer SM; Graham LM; Stanley JC
    Surgery; 1986 Aug; 100(2):369-75. PubMed ID: 3526609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of prostaglandins PGE1 and PGI2 in peripheral arterial ischemia.
    Cronenwett JL
    J Vasc Surg; 1986 Feb; 3(2):370-4. PubMed ID: 3511306
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience.
    Dormandy JA
    Vasc Med; 1996; 1(2):155-8. PubMed ID: 9546931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of the prostacyclin story for clinical use].
    Sinzinger H; Silberbauer K
    Vasa; 1981; 10(1):70-3. PubMed ID: 7015718
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage of the severely ischaemic limb by intra-arterial prostacyclin (PGI2) infusion. A case report.
    Søreide O; Segadal L; Trippestad A; Engedal H
    Scand J Thorac Cardiovasc Surg; 1982; 16(1):71-3. PubMed ID: 7041251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.
    Romson JL; Haack DW; Abrams GD; Lucchesi BR
    Circulation; 1981 Nov; 64(5):906-14. PubMed ID: 7026083
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease.
    Ylitalo P; Kaukinen S; Reinikainen P; Salenius JP; Vapaatalo H
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):197-204. PubMed ID: 1694831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.
    Olsson AG; Nilsson E
    Prostaglandins Med; 1981 Apr; 6(4):329-39. PubMed ID: 7025066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study.
    Nizankowski R; Królikowski W; Bielatowicz J; Szczeklik A
    Thromb Res; 1985 Jan; 37(1):21-8. PubMed ID: 3885472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia.
    Belch JJ; Ray S; Rajput-Ray M; Engeset J; Fagrell B; Lepäntalo M; McKay A; Mackay IR; Ostergren J; Ruckley CV; Salenius J
    Int Angiol; 2011 Apr; 30(2):150-5. PubMed ID: 21427652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics.
    Ernst E; Marshall M; Matrai A
    Vasa; 1988; 17(2):89-91. PubMed ID: 2457284
    [No Abstract]   [Full Text] [Related]  

  • 17. A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular disease.
    Virgolini I; Fitscha P; Linet OI; O'Grady J; Sinzinger H
    Prostaglandins; 1990 Jun; 39(6):657-64. PubMed ID: 2115186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical potential of prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():449-56. PubMed ID: 6221561
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostacyclin administration during cardiopulmonary bypass in man.
    Longmore DB; Bennett JG; Hoyle PM; Smith MA; Gregory A; Osivand T; Jones WA
    Lancet; 1981 Apr; 1(8224):800-4. PubMed ID: 6111672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefits of iloprost, a stable prostacyclin (PGI2) analog, in severe peripheral arterial disease (PAD).
    Oberender H; Krais T; Schäfer M; Belcher G
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():311-6. PubMed ID: 2473610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.